Invitae's Common Hereditary Cancers Panel Receives FDA Market Authorization
– First-of-its-kind authorization provides potential marketing differentiation and opportunities for largest testing category – – Testament to Invitae's product and lab quality – – Sets...
Source: marketscreener.com